COMPETE-LM Trial: Drug-Coated Balloon-Enhanced Provisional Stenting in Complex Left Main Disease.

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 186 participants.

Also called NCT07408674

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 186 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07408674
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07408674. Randomized; single masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2029-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
COMPETE-LM Trial: Drug-Coated Balloon-Enhanced Provisional Stenting in Complex Left Main Disease.
Acronym
COMPETE-LM
Condition
Complex Left Main Bifurcation Stenosis
Condition
Left Main Coronary Artery Stenosis
Condition
Coronary Bifurcation Stenosis
Intervention (Device)
Angiolite Sirolimus-Eluting Stenting
Intervention (Device)
Essential Pro Paclitaxel Drug-Eluting Balloon
Lead sponsor
Rede Optimus Hospitalar SA (class: research network)
Collaborator
iVascular S.L.U. (class: industry)

Record details

Record id
cardio:ct-nct07408674
Content hash
445cb5de4ab221953ef628103ac66fb17413c10ac64e7f791e217e7b4fd5a194